Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - Riot Blockchain, Inc.ex99x1.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported) March 31, 2014
 
 
Venaxis, Inc.
 
 
(Exact name of Registrant as specified in its charter)
 
 
 
Colorado
 
001-33675
 
84-1553387
(State or other jurisdiction of incorporation or organization)
 
(Commission File Number)
 
(I.R.S. Employer Identification No.)
 
 
1585 South Perry Street
Castle Rock, Colorado
 
80104
(Address of principal executive offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code:
 
(303) 794-2000
 

(Former name or former address, if changed since last report.)
 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 

 
Item 8.01.   Other Events.

On March 31, 2014, Venaxis, Inc. (the “Company”) issued a press release titled — “Venaxis Files for FDA Clearance of APPY1 Test.”  The press release is filed as Exhibit 99.1 to this Form 8-K.
 

Item 9.01.   Financial Statements and Exhibits

(d) Exhibits.

Exhibits

99.1
Press Release of Venaxis, Inc. titled “Venaxis Files for FDA Clearance of APPY1 Test,” issued March 31, 2014.


 
 
 

 

 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

         
 
Venaxis, Inc.
(Registrant)
 
 
March 31, 2014
By:  
 /s/ Jeffrey G. McGonegal  
 
   
Name:  
Jeffrey G. McGonegal
 
   
Title:  
Chief Financial Officer